Good morning :)
Place Order
Add to Watchlist

Trident Lifeline Ltd

TLL

Trident Lifeline Ltd

TLL
Pharmaceuticals
SmallcapWith a market cap of ₹349 cr, stock is ranked 1,977
High RiskStock is 5.93x as volatile as Nifty
304.050.00% (+0.00)
304.050.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Pharmaceuticals
SmallcapWith a market cap of ₹349 cr, stock is ranked 1,977
High RiskStock is 5.93x as volatile as Nifty

How to use scorecard? Learn more

Pharmaceuticals
SmallcapWith a market cap of ₹349 cr, stock is ranked 1,977
High RiskStock is 5.93x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
49.247.66
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
32.391.890.23%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Trident Lifeline Limited is engaged in the pharmaceutical business ethical marketing in domestic as well as international market. The Company is also engaged in distribution of pharmaceutical products through a third party distribution network. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nutraceutical and Non-steroidal anti-inflammatory drug (NSAIDS). Its product portfolio consists of approximately 832 products. It operates in India, as well as African, Latin American and East Indian countries.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2022FY 2023FY 2024TTM
Total Revenue22.3732.8546.7138.18
Raw Materialssubtract14.6923.1236.4428.56
Power & Fuel Costsubtract0.020.03
Employee Costsubtract1.101.28
Selling & Administrative Expensessubtract0.941.10
Operating & Other expensessubtract2.31-0.09
Depreciation/Amortizationsubtract0.200.360.970.54
Interest & Other Itemssubtract0.130.480.600.49
Taxes & Other Itemssubtract-0.960.562.351.49
EPS4.936.165.176.17
DPS0.000.000.000.00
Payout ratio0.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2023

Annual report

PDF

Investor Presentation

May 6PDF
 

Peers & Comparison

Comparing 3 stocks from 
Pharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Trident Lifeline Ltd55.067.66
Sun Pharmaceutical Industries Ltd39.525.640.86%
Cipla Ltd29.635.150.86%
Zydus Lifesciences Ltd30.646.010.26%

Price Comparison

Compare TLL with any stock or ETF
Compare TLL with any stock or ETF
TLL
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.56%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.38%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.48%0.00%0.00%6.02%26.50%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar4.20%4.39%4.36%4.64%4.64%6.02%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

TLL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time

News & Opinions

Hmm, looks like data is unavailable here. Please come back after some time.